Clinical trials: active, sponsored by University of Oklahoma
Chronic Pain Due to Cancer, Pain Catastrophizing
Empowered Relief® for Cancer Survivors With Chronic Pain
This randomized controlled study to examine the efficacy of ER class in cancer survivors with chronic pain. Eligible participants will be randomly assigned to a ER class or a waitlist control condition.
- Trial name
- NCT07578376
- Testing
- Empowered Relief Course (Zoom)
- Where
- United States
- Volunteers
- 215 people
- Sponsor
- University of Oklahoma
Prostate Cancer
MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy
The purpose of this study is to find out how best to detect clinically significant lesions of prostate cancer by using micro-ultrasound technology (ExactVu) and by multiparametric magnetic-resonance imaging (mpMRI).
- Trial name
- OU-SCC-PROBX (NCT05471128)
- Testing
- Standard of Care Biopsy
- Where
- United States
- Volunteers
- 29 people
- Sponsor
- University of Oklahoma
Pancreatic Ductal Adenocarcinoma (PDAC)
Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer
The purpose of this research is to observe the effects of using a new combination of drugs to inhibit tumor growth.
- Trial name
- FALCON (NCT07829185)
- Testing
- modified FOLFIRINOX, Pentamidine 300 MG Injection
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- University of Oklahoma
Solid Tumor, Adult
Advanced or Recurrent Solid Tumors Treated With SHetA2
The purpose of this research is to test the safety of the study drug (OK-1) and see what effects (good and bad) this drug has on patients with recurrent solid tumors.
- Trial name
- Okgyn1 (NCT04928508)
- Testing
- OK-1
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- University of Oklahoma
Smoking Cessation, HIV
Smoking Cessation Program for Lao People With HIV
Tobacco use remains the leading modifiable risk factor for preventing cancer globally, particularly among people with HIV (PWH). In Laos, 61-80% of male PWH and 3-10% of female PWH smoke cigarettes.
- Trial name
- I-STOP (NCT07014605)
- Testing
- Smoking Cessation Self Help Guide, Smartphone-delivered Automated Messaging
- Where
- 2 sites in Laos
- Volunteers
- 1,200 people
- Sponsor
- University of Oklahoma
Pancreas Cancer
ctDNA Assay in Patients With Resectable Pancreatic Cancer
The purpose of this study is to determine the proportion of positive ctDNA -freely circulating tumor DNA fragments found in the blood plasma- in patients with pancreatic cancer and to better understand the relationship between…
- Trial name
- OU-SCC-ctDNA (NCT05052671)
- Where
- 2 sites in United States
- Volunteers
- 50 people
- Sponsor
- University of Oklahoma
Breast Cancer, Lymphoma
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
This study is to determine if low level vagus nerve stimulation will lead to improvement in heart function, heart rate variation, and in the levels of certain chemical markers of inflammation in study participants' blood.
- Trial name
- OU-SCC-NCAN (NCT05921253)
- Testing
- PARASYM neuromodulation device
- Where
- 2 sites in United States
- Volunteers
- 104 people
- Sponsor
- University of Oklahoma
Head and Neck Cancer
Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse
This 2-arm phase II study proposes to determine the efficacy of ketamine oral rinse in pain relief from mucositis in head and neck cancer patients undergoing radiation treatment.
- Trial name
- NCT06660017
- Testing
- Ketamine Topical
- Where
- United States
- Volunteers
- 62 people
- Sponsor
- University of Oklahoma
Patient Outcomes
Program in Oncology for Tribal Health Systems.
This clinical trial aims to develop and implement more navigation assistance programs tailored specifically for Native American cancer patients, addressing the current lack of available support.
- Trial name
- NCT07217574
- Testing
- C3PO
- Where
- United States
- Volunteers
- 187 people
- Sponsor
- University of Oklahoma
Endometrial Cancer
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
This is a single arm, Phase II study using the combination of atezolizumab and bevicacizumab in women with advanced, recurrent or persistent endometrial cancer.
- Trial name
- NCT03526432
- Testing
- Bevacizumab, Atezolizumab
- Where
- 3 sites in United States
- Volunteers
- 110 people
- Sponsor
- University of Oklahoma
Prostate Cancer, Renal Cell Carcinoma (RCC)
Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)
The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prespecified cancers of interest.
- Trial name
- NCT06960798
- Testing
- Bio-specimen Collection, Blood Draw
- Where
- United States
- Volunteers
- 300 people
- Sponsor
- University of Oklahoma
Acute Decompensated Heart Failure
Low Level Tragus Stimulation in Acute Decompensated Heart Failure
Acute Decompensated Heart Failure (ADHF) is a major cause of morbidity and mortality. It is associated with increased systemic inflammation.
- Trial name
- TREAT-HF (NCT02898181)
- Testing
- Neuromodulation
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- University of Oklahoma
Brain Aging, Cerebrovascular Function
AKG and Brain Health in Aging
This proposal will test the hypothesis that AKG supplementation will improve NGVC responses and cognitive performance in older adults.
- Trial name
- NCT07861867
- Testing
- Calcium AKG
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- University of Oklahoma
Proton Therapy, Radiation Therapy, Secondary Skin Reactions
Protoacoustic Imaging For 3D Mapping
The purpose of this study is to test a new imaging technology called radioacoustic imaging (RAI) that may help doctors see where radiation is being delivered during proton therapy.
- Conditions
- Proton Therapy, Radiation Therapy, Secondary Skin Reactions, Liver Cancer, Prostate Cancer
- Trial name
- NCT07832617
- Testing
- Radiacoustic Imaging w/Ultrasound.
- Where
- United States
- Volunteers
- 24 people
- Sponsor
- University of Oklahoma
Breast Cancer
Biopsy-site-marker in Breast Cancer
The purpose of this study is to explore pro-metastatic changes in breast cancer (BC) associated with the stiffness of biopsy site markers.
- Trial name
- NCT07833566
- Testing
- Biopsy-Site Marker Placement.
- Where
- United States
- Volunteers
- 140 people
- Sponsor
- University of Oklahoma
Immune Checkpoint Inhibitors, Metastatic Solid Tumor
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
The aim of this study is to describe the outcomes in American Indian patients receiving immunotherapy in a multi-institution retrospective study at several other high-volume centers that care for this patient population and to…
- Conditions
- Immune Checkpoint Inhibitors, Metastatic Solid Tumor, Nonsmall Cell Lung Cancer, Melanoma
- Trial name
- NCT05863052
- Testing
- Immunotherapy
- Where
- 6 sites in United States
- Volunteers
- 72 people
- Sponsor
- University of Oklahoma
Glioblastoma
OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
This is a pilot study exploring the potential benefit of adding OKN-007 with Temozolomide for treatment in patients with malignant Glioblastoma undergoing adjuvant concomitant radiotherapy.
- Trial name
- NCT03587038
- Testing
- OKN 007, Temozolomide, Photon/Proton IMRT
- Where
- United States
- Volunteers
- 27 people
- Sponsor
- University of Oklahoma
Cancer, Pain
Feasibility and Acceptability of Empowered Relief for American Indians With Pain During and After Cancer Treatment
This project will evaluate the feasibility and acceptability of Empowered Relief (ER) among American Indian adults who are currently receiving or have completed active cancer treatments at Stephenson Cancer Center (SCC).
- Conditions
- Cancer, Pain, Pain Management, Chronic Pain
- Trial name
- ejames3 (NCT07742449)
- Testing
- Empowered Relief
- Where
- United States
- Volunteers
- 70 people
- Sponsor
- University of Oklahoma
Risk Perceptions, Decision Making
Designing Effective Alcohol Health Warnings: An Experimental Study With Adults in the U.S.
Consuming alcohol is a dose-dependent and modifiable risk factor for breast cancer. Although alcohol consumption contributes to an estimated 16% of breast cancer cases, awareness of the link between alcohol and breast cancer risk…
- Conditions
- Risk Perceptions, Decision Making, Alcohol
- Trial name
- NCT07812545
- Testing
- Health warning statement evaluations (bottles), Health warning statement evaluations (ads)
- Where
- United States
- Volunteers
- 2,000 people
- Sponsor
- University of Oklahoma
Paramedian Forehead Flap
Topical CBD Scar Healing Study
The purpose of this study is to find out what effects (good and bad) that cannabidiol (CBD) has on scar healing and appearance in patients who have undergone paramedian forehead flap reconstruction.
- Trial name
- NCT06129591
- Testing
- Vantage Hemp CBD Isolate + Silicone patch, Silicone patch
- Where
- United States
- Volunteers
- 22 people
- Sponsor
- University of Oklahoma